Drug shortages in Saudi Arabia: Root causes and recommendations

Saudi Pharmaceutical Journal - Tập 26 Số 7 - Trang 947-951 - 2018
Yazed AlRuthia1,2,3, Monira Alwhaibi1, Mashal F. Alotaibi1, Shatha A. Asiri1, Bushra M. Alghamdi1, Ghadah S. Almuaythir1, Wejdan R. Alsharif1, Hala Alrasheed1, Yahya A. Alswayeh4, Abdulaziz J. Alotaibi5, Mohammad Almeshal6, Saleh N. Aldekhail7,8, Abdulrahman Alhusaini9, Sulaiman A. Alrashed10, Ali M. Alrumaih11, Mohammed A. Dahhas12, Mohammed Alghamdi13, Mohammad S. Aleheidib14, Mohamed H. Alhaidari15, Jameel A. Alharbi16, Aws Alshamsan
1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
2Pharmacoeconomics Research Unit, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
3Pharmacy Education Unit, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
4General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, Saudi Arabia
5Department of Medical Supply, General Directorate of Medical Services, Ministry of Interior, Riyadh, Saudi Arabia
6Former Chief Executive Officer of the Saudi Food and Drug Authority, Riyadh, Saudi Arabia
7Department of Pharmacy Practice, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
8Pharmaceutical Care Services, King Abdulaziz Medical City, National Guard-Health Affairs, Ministry of National Guard, Riyadh, Saudi Arabia
9Department of Supply Chain Management, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
10Department of Medical Supply, Medical Services for Armed Forces, Ministry of Defense, Riyadh, Saudi Arabia
11Department of Pharmaceutical Care, Medical Services for Armed Forces, Ministry of Defense, Riyadh, Saudi Arabia
12Department of Inspection and Law Enforcement, Saudi Food and Drug Authority, Riyadh, Saudi Arabia
13Department of Contracts and Purchasing, Prince Sultan Military Medical City, Ministry of Defense, Riyadh, Saudi Arabia
14National Antivenom and Vaccines Production Center, Ministry of National Guard, Riyadh, Saudi Arabia
15Former Head of Drug Central Registration Department and Executive Board, Health Ministers’ Council for Cooperation Council States, Riyadh, Saudi Arabia
16Department of Pricing and Pharmacoeconomics, Saudi Food and Drug Authority, Riyadh, Saudi Arabia

Tóm tắt

Từ khóa


Tài liệu tham khảo

Adamski, 2010, Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers, BMC Health Serv. Res., 10, 153, 10.1186/1472-6963-10-153

Allen, 2012, Drug shortages & discontinued drugs: the effects on patients & healthcare providers, Int. J. Pharm. Compd., 16, 294

AlRuthia, 2017, Drug shortages in large hospitals in Riyadh: a cross-sectional study, Ann. Saudi Med., 37, 375, 10.5144/0256-4947.2017.375

Alshehri, 2016, Drug supply shortages in pharmacies: causes and solutions; a case study in King Khaled Eye Special Hospital, Int. Bus. Manage., 10, 2453

Alsheikh, 2016, A comparison of drug shortages in the hospital setting in the United States and Saudi Arabia: an exploratory analysis, Hosp. Pharm., 51, 370, 10.1310/hpj5105-370

APICS. American Production and Inventory Control Society, 2014.Available at <http://www.apics.org/docs/default-source/education/2014-apics-productionand-inventory-management-journal.pdf> (accessed on 12th March 2018).

Balkhi, 2013, Shortages of systemic antibiotics in the USA: how long can we wait?, J. Pharm. Heal Serv. Res., 4, 13, 10.1111/jphs.12006

Barlas, 2013, FDA strategies to prevent and respond to drug shortages: finding a better way to predict and prevent company closures, Pharm. Therapeut., 38, 261

Dranitsaris, 2017, Drug tendering: drug supply and shortage implications for the uptake of biosimilars, ClinicoEconomics Outcomes Res.: CEOR, 9, 573, 10.2147/CEOR.S140063

Food and Drug Administration Safety and Innovation Act, USC (2012). Pub L 112–114.

Fox, 2014, Drug shortages: a complex health care crisis, Mayo Clin. Proc., 89, 361, 10.1016/j.mayocp.2013.11.014

Gray, 2012, Shortages of medicines: a complex global challenge, Bull. World Health Organ., 90, 10.2471/BLT.11.101303

Haaijer, R.D.M., Joncheere, R.D.M., 2003. The Netherlands: IOS Press Ohmsha (Published on behalf of WHO Regional Office Europe), 112-31.

Iqbal, 2017, Medicines management in hospitals: a supply chain perspective, Syst. Rev. Pharm., 8, 80, 10.5530/srp.2017.1.14

Johnston, 2014, Substandard drugs: a potential crisis for public health, Br. J. Clin. Pharmacol., 78, 218, 10.1111/bcp.12298

Lipworth, 2013, Why drug shortages are an ethical issue, Aust. Med. J., 6, 556, 10.4066/AMJ.2013.1869

Management Sciences for Health, 2012, Managing the tender process, 401

MSH. Rational pharmaceutical management plus program (RPM Plus), 2009. A Guide for implementing the Monitoring-Training-Planning (MTP) Approach to build skills for pharmaceutical management. Management Sciences for Health, Arlington, VA. Available at <http://pdf.usaid.gov/pdf_docs/Pdaco309.pdf> (accessed on March 11th 2018).

Pauwels, 2014, Drug shortages in European countries: a trade-off between market attractiveness and cost containment?, BMC Health Services Res., 14, 438, 10.1186/1472-6963-14-438

Pauwels, 2015, Insights into European drug shortages: a survey of hospital pharmacists, PloS One, 10, e0119322, 10.1371/journal.pone.0119322

Rasooldeen, M., 2017. Saudi Arabia Aims to Boost Pharmaceutical Industry. Arab News (Jeddah, Saudi Arabia). <http://www.highbeam.com/doc/1G1-481615675.html?refid=easy_hf>. Published February 11, 2017 (accessed March 11, 2018).

Reis, 2008, Drug shortage: determinants, consequences and management, Cien Saude Colet., 13, 603, 10.1590/S1413-81232008000700009

Setayesh, 2016, Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy, Globalization Health, 12, 31, 10.1186/s12992-016-0168-6

Tawde, 2014, Particulate matter in injectables: main cause for recalls, J. Pharmacovigilance, 3, 1000

Ten Ham, 2003, Health risks of counterfeit pharmaceuticals, Drug Saf., 26, 991, 10.2165/00002018-200326140-00001

US Department of Health and Human Services, 2011. Drug shortages. ASPE Issue Brief. <https://aspe.hhs.gov/sites/default/files/pdf/108986/ib.pdf> (Published 2011).

WHO. World Health Organization, 1988. Estimating drug requirements: a practical manual. WHO, Geneva. WHO/DAP/88. Available at <http://apps.who.int/medicinedocs/pdf/h2931e/h2931e.pdf> (accessed on March 10th, 2018).

World Health Organization, 1999. Operational principles for good pharmaceutical procurement. 1999. Available from: <http://www.who.int/3by5/en/who-edm-par-99-5.pdf> (accessed March 11, 2018).

World Health Organization, 2014. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser. (986), 1–387. Available at: <http://apps.who.int/medicinedocs/en/d/Js21464en/> (accessed March 12, 2018).

WHO. The Selection and Use of Essential Medicines, 2017. <http://apps.who.int/iris/bitstream/10665/259481/1/9789241210157-eng.pdf?ua=1> (accessed on March 12th 2018).

Yang, 2016, Current situation, determinants, and solutions to drug shortages in shaanxi province, china: a qualitative study, PLoS ONE, 11, e0165183, 10.1371/journal.pone.0165183

Thông tin
Thông tin xuất bản

Saudi Pharmaceutical Journal

Tập 26 Số 7

947-951

Thông tin tác giả